Zurich Cantonal Bank’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $438K | Buy |
86,497
+9,767
| +13% | +$49.4K | ﹤0.01% | 1742 |
|
|
2025
Q1 | $406K | Buy |
76,730
+10,272
| +15% | +$54.3K | ﹤0.01% | 1723 |
|
|
2024
Q4 | $449K | Buy |
66,458
+13,928
| +27% | +$94.2K | ﹤0.01% | 1690 |
|
|
2024
Q3 | $346K | Buy |
52,530
+2,667
| +5% | +$17.6K | ﹤0.01% | 1789 |
|
|
2024
Q2 | $374K | Buy |
49,863
+14,060
| +39% | +$105K | ﹤0.01% | 1689 |
|
|
2024
Q1 | $357K | Sell |
35,803
-4,855
| -12% | -$48.4K | ﹤0.01% | 1689 |
|
|
2023
Q4 | $401K | Buy |
40,658
+10,033
| +33% | +$98.9K | ﹤0.01% | 1652 |
|
|
2023
Q3 | $234K | Sell |
30,625
-508
| -2% | -$3.89K | ﹤0.01% | 1869 |
|
|
2023
Q2 | $233K | Buy |
31,133
+12,179
| +64% | +$91K | ﹤0.01% | 1827 |
|
|
2023
Q1 | $126K | Hold |
18,954
| – | – | ﹤0.01% | 2157 |
|
|
2022
Q4 | $146K | Buy |
18,954
+3,997
| +27% | +$30.8K | ﹤0.01% | 2024 |
|
|
2022
Q3 | $159K | Sell |
14,957
-187
| -1% | -$1.99K | ﹤0.01% | 1897 |
|
|
2022
Q2 | $123K | Buy |
+15,144
| New | +$123K | ﹤0.01% | 2100 |
|
|
2022
Q1 | – | Sell |
-16,065
| Closed | -$275K | – | 2820 |
|
|
2021
Q4 | $275K | Buy |
16,065
+8,239
| +105% | +$141K | ﹤0.01% | 1867 |
|
|
2021
Q3 | $180K | Buy |
+7,826
| New | +$180K | ﹤0.01% | 1994 |
|